Ahmedabad: At the backdrop of discontinuation of its liquids business in the US and headwinds faced by its EU business, Torrent Pharmaceuticals Limited posted 38% decline in its consolidated net profit, which closed at Rs 777 crore for financial year 2021-22 from Rs 1,252 crore in the previous fiscal year. The company’s revenues grew 6% to Rs 8,508 crore during the fiscal year.
The company had to bear an exceptional item of Rs 485 crore on account of impairment provision and costs related to discontinuation of liquid business in the US. tnn